Testing effectiveness (Phase 2)UnknownNCT00955630
What this trial is testing
Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Who this might be right for
Ocular Histoplasmosis Syndrome
Retina Associates of Kentucky 20